Stoke Therapeutics's total assets for Q4 2024 were $271.56M, a decrease of -7.42% from the previous quarter. STOK total liabilities were $42.53M for the fiscal quarter, a -30.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.